Protective Role of Selenium-Binding Protein 1 (SELENBP1) in Patients with Ulcerative Colitis

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Selenium-binding protein 1 (SELENBP1) plays a role in selenium absorption and has immunoregulatory effects.
• SELENBP1's role in ulcerative colitis (UC) pathogenesis and clinical outcomes is not well understood.
• Investigating SELENBP1 expression in UC patients is crucial for understanding its potential impact.

Purpose of the Study:

• To determine the clinical outcome of SELENBP1 expression in colonic tissue from patients with UC.
• To analyze the association between SELENBP1 gene expression levels and UC clinical activity.
• To explore the localization of SELENBP1 in the colonic tissue of UC patients.

Main Methods:

• Analysis of relative mRNA expression of SELENBP1 in 34 UC patients and 20 controls.
• Statistical analysis using SPSS 19.
• Histological assessment and correlation with SELENBP1 expression levels.

Main Results:

• SELENBP1 gene expression was significantly lower in active UC patients compared to those in remission and controls.
• Overexpression of SELENBP1 was linked to a more benign clinical course, including prolonged remission and intermittent disease patterns.
• SELENBP1-positive cells were predominantly found in the inflammatory infiltrate of active UC colonic tissue.

Conclusions:

• Upregulation of SELENBP1 is associated with a benign clinical course in ulcerative colitis.
• This study provides the first evidence for an immunoregulatory role of SELENBP1 in UC patients.
• SELENBP1 may serve as a potential biomarker for disease activity and prognosis in UC.